TITAN™ Reverse Shoulder System

NCT ID: NCT02204228

Last Updated: 2025-09-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

151 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-09-30

Study Completion Date

2023-12-14

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The Integra® TITAN™ Reverse Shoulder System (TRS) is a semi-constrained total shoulder construct. When used under the conditions and purposes intended the TRS will relieve pain and restore some functional joint motion to the affected shoulder. The purpose of this study is to assess the short, mid and long term outcomes of the TITAN™ Reverse Shoulder System.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Osteoarthritis of the Shoulder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

TITAN™ Reverse Shoulder System (TRS)

TITAN™ Reverse Shoulder System (TRS) is a semi-constrained total shoulder construct.

TITAN™ Reverse Shoulder System (TRS)

Intervention Type DEVICE

All patients will be operated on with the TITAN™ Reverse Shoulder System (TRS).

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

TITAN™ Reverse Shoulder System (TRS)

All patients will be operated on with the TITAN™ Reverse Shoulder System (TRS).

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subjects with grossly deficient rotator cuff with severe arthropathy or Subjects with failed joint replacement with grossly deficient rotator cuff
* Subjects with a shoulder joint anatomically and structurally suited to receive the device
* Subjects at least 21 years of age and skeletally mature at the time of surgery
* Subject provided consent to participate in the clinical study (having signed the Informed Consent Form)

Exclusion Criteria

* Subjects without a functional deltoid muscle
* Subjects with active local or systemic infection
* Subjects with inadequate bone stock in the proximal humerus or glenoid fossa for supporting the components
* Subjects with poor bone quality such as osteoporosis where there could be considerable migration of the prosthesis and/or a chance of fracture of the humerus or glenoid
* Subjects with muscular, neurologic, or vascular deficiencies that compromise the affected extremity
* Subjects with known metal allergies
* Subjects are known to be at risk for lost to follow-up, or failure to return for scheduled visits
* Subjects who are prisoners
* Female subject who are pregnant, nursing, or of childbearing potential while not practicing effective contraceptive methods
Minimum Eligible Age

21 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Smith & Nephew, Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Karlie Morgan

Role: STUDY_DIRECTOR

Smith & Nephew, Inc.

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Florida

Gainesville, Florida, United States

Site Status

Johns Hopkins University

Columbia, Maryland, United States

Site Status

Mississipi Bone and Joint Clinic

Starkville, Mississippi, United States

Site Status

Active Orthopedics

Glen Ridge, New Jersey, United States

Site Status

Westphal Orthopaedics

Lancaster, Pennsylvania, United States

Site Status

Hospital of the University of Pennsylvania

Philadelphia, Pennsylvania, United States

Site Status

The Rothman Institute

Philadelphia, Pennsylvania, United States

Site Status

Clinique Bizet

Paris, , France

Site Status

Hospital de Manacor - Llevant

Manacor, , Spain

Site Status

Barts Health NHS Trust

London, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States France Spain United Kingdom

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CP-0960-001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Database Retrieval for the Comprehensive Shoulder
NCT03409718 ACTIVE_NOT_RECRUITING
Comprehensive SRS Regenerex Tissue Attachment
NCT06615739 ACTIVE_NOT_RECRUITING
Pinnacle RSA Study
NCT04070989 TERMINATED NA